Oncoclínicas do Brasil Serviços Médicos S.A.

B3:ONCO3.SA

5.06 (BRL) • At close July 1, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) BRL.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 1,566.041,634.8911,567.631,458.6661,434.2461,401.5481,359.5231,293.4591,216.5281,163.872899.9807.952767.879679.42640.215614.552574.319524.858482.655453.359
Cost of Revenue 1,062.9621,086.7991,040.662976.386947.481905.766884.039822.914764.437756.473578.614536.621502.267460.52450.706419.782385.881356.661330.86326.112
Gross Profit 503.078548.092526.968482.28486.765495.782475.484470.545452.091407.399321.286271.331265.612218.9189.509194.77188.438168.197151.795127.247
Gross Profit Ratio 0.3210.3350.3360.3310.3390.3540.350.3640.3720.350.3570.3360.3460.3220.2960.3170.3280.320.3150.281
Reseach & Development Expenses 00000.037000000000000000
General & Administrative Expenses 412.919355.756311.121316.967303.865308.746288.221271.237255.198277.121248.094200.404194.53218.408335.529139.581248.869112.286118.267115.673
Selling & Marketing Expenses 00000000000000000000
SG&A 412.919355.756311.121316.967303.865308.746288.221271.237255.198277.121248.094200.404194.53218.408335.529139.581248.869112.286118.267115.673
Other Expenses 793.2227.31303.466000-9.437-994.02900-655.073000-0.20325.7520.8288.0255.977
Operating Expenses 1,206.141363.069311.121316.967303.865312.327288.089264.479-738.831276.291245.308-454.669192.49422.538337.166139.378-192.234113.114131.286121.65
Operating Income -703.063185.023215.847161.847182.9180.065187.263195.213470.565130.27875.978106.01171.08200.492-147.65755.392-86.18355.08325.5035.597
Operating Income Ratio -0.4490.1130.1380.1110.1280.1280.1380.1510.3870.1120.0840.1310.0930.295-0.2310.09-0.150.1050.0530.012
Total Other Income Expenses Net -13.592-135.976-179.99-186.95-63.758-142.12-116.774-120.271-405.437-95.386-70.469-90-20.469-32.719-36.133-27.65-12.546-14.949-15.132-14.491
Income Before Tax -716.65549.04735.857-25.103119.14237.94570.48974.94265.12834.8925.50916.01150.611167.773-183.7927.742-98.72940.13410.371-8.894
Income Before Tax Ratio -0.4580.030.023-0.0170.0830.0270.0520.0580.0540.030.0060.020.0660.247-0.2870.045-0.1720.0760.021-0.02
Income Tax Expense 42.53945.92616.797-44.69232.104-111.38735.51933.72-31.816-22.15330.10231.63627.88216.98518.73821.14924.78717.7814.02211.498
Net Income -643.144-15.943.3029.59275.439104.98921.00622.18471.11430.833-32.694-22.99315.292145.177-204.888-2.481-142.61414.069-9.327-21.747
Net Income Ratio -0.411-0.010.0020.0070.0530.0750.0150.0170.0580.026-0.036-0.0280.020.214-0.32-0.004-0.2480.027-0.019-0.048
EPS -0.97-0.0270.0060.0180.150.20.0410.0430.150.065-0.069-0.0480.0320.31-0.51-0.006-0.360.035-0.023-0.054
EPS Diluted -0.97-0.0280.0060.0170.140.20.040.0430.140.065-0.069-0.0480.0320.31-0.51-0.006-0.360.035-0.023-0.054
EBITDA -488.261284.248265.129199.503325.753244.175280.637277.735214.005183.308165.272140.77133.203236.527-113.58392.594-36.87862.88749.31127.507
EBITDA Ratio -0.3120.1740.1690.1370.2270.1740.2060.2150.1760.1570.1840.1740.1730.348-0.1770.151-0.0640.120.1020.061